The level of the pro-inflammatory factor IL-1β was significantly decreased and the levels of anti-inflammatory factors eNOS, TGFβ, Arg1, and IL-10 were significantly increased after GLSP treatment in early and advanced atherosclerosis (Figure 3E-F). This evidence concerns the gene IL1B and atherosclerosis.